针对Sortilin的反义寡核苷酸以性别依赖的方式减少小鼠血管钙化。

IF 7.4 1区 医学 Q1 HEMATOLOGY
Adrien Lupieri, Dakota Becker-Greene, Thanh-Dat Le, Marina M Roschel, Prabhash K Jha, Abhijeet R Sonawane, Adam Mullick, Sotirios Tsimikas, Shiori Kuraoka, Sasha A Singh, Masanori Aikawa, Elena Aikawa
{"title":"针对Sortilin的反义寡核苷酸以性别依赖的方式减少小鼠血管钙化。","authors":"Adrien Lupieri, Dakota Becker-Greene, Thanh-Dat Le, Marina M Roschel, Prabhash K Jha, Abhijeet R Sonawane, Adam Mullick, Sotirios Tsimikas, Shiori Kuraoka, Sasha A Singh, Masanori Aikawa, Elena Aikawa","doi":"10.1161/ATVBAHA.124.321999","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Atherosclerotic calcification is a complex pathological process associated with an increased risk of cardiovascular events. Despite extensive research, this disorder has no effective therapeutic strategies. In this study, we evaluated the therapeutic potential of silencing Sort (sortilin) expression in vivo using antisense oligonucleotide (ASO-Sort1) to reduce the development of atherosclerosis and associated calcification.</p><p><strong>Methods: </strong>Male and female <i>Ldlr</i><sup>-/-</sup> (low-density lipoprotein receptor knock-out) mice were fed a high-fat diet and treated with ASO-Sort1 for 15 weeks. After ASO-Sort1 treatment, we evaluated atherosclerotic lesion formation and calcification through molecular imaging and histological techniques. The levels of plasma lipid and inflammatory molecules were determined. Unbiased liquid chromatography-mass spectrometry-based proteomics of aortic arches was conducted to investigate the sex-specific regulation in ASO-Sort1-treated mice. To validate our in vivo findings, we conducted in vitro experiments to examine whether β-estradiol treatment of mouse smooth muscle cells promotes calcification independently of Sort.</p><p><strong>Results: </strong>ASO targeted primarily arterial smooth muscle cells, leading to a comparable reduction of aortic Sort1 expression by ≈57% in males and 52% in females. Although ASO-Sort1 did not affect the size of atherosclerotic lesions, it significantly reduced necrotic core development by 60% in male and 40% in female mice. In addition, it prevented aortic calcification by >50% only in male mice. Furthermore, proteome analysis revealed that while this treatment reduced vesicular trafficking, immune system, and extracellular matrix organization pathways in both male and female mice, it reduced autophagy-related processes specifically in males. In vitro results indicated that β-estradiol promotes calcification in smooth muscle cells treated with ASO-Sort1 by altering autophagy.</p><p><strong>Conclusions: </strong>Targeting Sort using antisense technology is effective in preventing vascular calcification in male mice. This unexpected outcome highlighted a novel sex-dependent discrepancy of the calcification pathway implicating the alteration of autophagy by β-estradiol and Sort.</p>","PeriodicalId":8401,"journal":{"name":"Arteriosclerosis, Thrombosis, and Vascular Biology","volume":" ","pages":"1398-1415"},"PeriodicalIF":7.4000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antisense Oligonucleotide Targeting Sortilin Reduces Vascular Calcification in Mice in a Sex-Dependent Manner.\",\"authors\":\"Adrien Lupieri, Dakota Becker-Greene, Thanh-Dat Le, Marina M Roschel, Prabhash K Jha, Abhijeet R Sonawane, Adam Mullick, Sotirios Tsimikas, Shiori Kuraoka, Sasha A Singh, Masanori Aikawa, Elena Aikawa\",\"doi\":\"10.1161/ATVBAHA.124.321999\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Atherosclerotic calcification is a complex pathological process associated with an increased risk of cardiovascular events. Despite extensive research, this disorder has no effective therapeutic strategies. In this study, we evaluated the therapeutic potential of silencing Sort (sortilin) expression in vivo using antisense oligonucleotide (ASO-Sort1) to reduce the development of atherosclerosis and associated calcification.</p><p><strong>Methods: </strong>Male and female <i>Ldlr</i><sup>-/-</sup> (low-density lipoprotein receptor knock-out) mice were fed a high-fat diet and treated with ASO-Sort1 for 15 weeks. After ASO-Sort1 treatment, we evaluated atherosclerotic lesion formation and calcification through molecular imaging and histological techniques. The levels of plasma lipid and inflammatory molecules were determined. Unbiased liquid chromatography-mass spectrometry-based proteomics of aortic arches was conducted to investigate the sex-specific regulation in ASO-Sort1-treated mice. To validate our in vivo findings, we conducted in vitro experiments to examine whether β-estradiol treatment of mouse smooth muscle cells promotes calcification independently of Sort.</p><p><strong>Results: </strong>ASO targeted primarily arterial smooth muscle cells, leading to a comparable reduction of aortic Sort1 expression by ≈57% in males and 52% in females. Although ASO-Sort1 did not affect the size of atherosclerotic lesions, it significantly reduced necrotic core development by 60% in male and 40% in female mice. In addition, it prevented aortic calcification by >50% only in male mice. Furthermore, proteome analysis revealed that while this treatment reduced vesicular trafficking, immune system, and extracellular matrix organization pathways in both male and female mice, it reduced autophagy-related processes specifically in males. In vitro results indicated that β-estradiol promotes calcification in smooth muscle cells treated with ASO-Sort1 by altering autophagy.</p><p><strong>Conclusions: </strong>Targeting Sort using antisense technology is effective in preventing vascular calcification in male mice. This unexpected outcome highlighted a novel sex-dependent discrepancy of the calcification pathway implicating the alteration of autophagy by β-estradiol and Sort.</p>\",\"PeriodicalId\":8401,\"journal\":{\"name\":\"Arteriosclerosis, Thrombosis, and Vascular Biology\",\"volume\":\" \",\"pages\":\"1398-1415\"},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Arteriosclerosis, Thrombosis, and Vascular Biology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1161/ATVBAHA.124.321999\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arteriosclerosis, Thrombosis, and Vascular Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/ATVBAHA.124.321999","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/12 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:动脉粥样硬化性钙化是一个复杂的病理过程,与心血管事件的风险增加有关。尽管广泛的研究,这种疾病没有有效的治疗策略。在这项研究中,我们评估了使用反义寡核苷酸(ASO-Sort1)在体内沉默Sort (sortilin)表达以减少动脉粥样硬化和相关钙化的治疗潜力。方法:雄性和雌性Ldlr-/-小鼠分别饲喂高脂饲料和ASO-Sort1治疗15周。在ASO-Sort1治疗后,我们通过分子成像和组织学技术评估动脉粥样硬化病变的形成和钙化。测定血脂和炎症分子水平。以无偏液相色谱-质谱为基础的主动脉弓蛋白质组学研究aso - sort1处理小鼠的性别特异性调控。为了验证我们在体内的发现,我们进行了体外实验,以检验β-雌二醇处理小鼠平滑肌细胞是否独立于Sort促进钙化。结果:ASO主要靶向动脉平滑肌细胞,导致男性主动脉Sort1表达降低约57%,女性主动脉Sort1表达降低约52%。虽然ASO-Sort1不影响动脉粥样硬化病变的大小,但它在雄性小鼠中显著减少了60%,在雌性小鼠中显著减少了40%。此外,仅在雄性小鼠中,它对主动脉钙化的抑制作用为50%。此外,蛋白质组学分析显示,虽然这种治疗减少了雄性和雌性小鼠的囊泡运输、免疫系统和细胞外基质组织途径,但它特异性地减少了雄性小鼠的自噬相关过程。体外实验结果表明,β-雌二醇通过改变自噬来促进ASO-Sort1处理的平滑肌细胞的钙化。结论:利用反义靶向分选技术可有效预防雄性小鼠血管钙化。这一意想不到的结果强调了一种新的性别依赖性钙化途径的差异,暗示了β-雌二醇和Sort对自噬的改变。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Antisense Oligonucleotide Targeting Sortilin Reduces Vascular Calcification in Mice in a Sex-Dependent Manner.

Background: Atherosclerotic calcification is a complex pathological process associated with an increased risk of cardiovascular events. Despite extensive research, this disorder has no effective therapeutic strategies. In this study, we evaluated the therapeutic potential of silencing Sort (sortilin) expression in vivo using antisense oligonucleotide (ASO-Sort1) to reduce the development of atherosclerosis and associated calcification.

Methods: Male and female Ldlr-/- (low-density lipoprotein receptor knock-out) mice were fed a high-fat diet and treated with ASO-Sort1 for 15 weeks. After ASO-Sort1 treatment, we evaluated atherosclerotic lesion formation and calcification through molecular imaging and histological techniques. The levels of plasma lipid and inflammatory molecules were determined. Unbiased liquid chromatography-mass spectrometry-based proteomics of aortic arches was conducted to investigate the sex-specific regulation in ASO-Sort1-treated mice. To validate our in vivo findings, we conducted in vitro experiments to examine whether β-estradiol treatment of mouse smooth muscle cells promotes calcification independently of Sort.

Results: ASO targeted primarily arterial smooth muscle cells, leading to a comparable reduction of aortic Sort1 expression by ≈57% in males and 52% in females. Although ASO-Sort1 did not affect the size of atherosclerotic lesions, it significantly reduced necrotic core development by 60% in male and 40% in female mice. In addition, it prevented aortic calcification by >50% only in male mice. Furthermore, proteome analysis revealed that while this treatment reduced vesicular trafficking, immune system, and extracellular matrix organization pathways in both male and female mice, it reduced autophagy-related processes specifically in males. In vitro results indicated that β-estradiol promotes calcification in smooth muscle cells treated with ASO-Sort1 by altering autophagy.

Conclusions: Targeting Sort using antisense technology is effective in preventing vascular calcification in male mice. This unexpected outcome highlighted a novel sex-dependent discrepancy of the calcification pathway implicating the alteration of autophagy by β-estradiol and Sort.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
2.30%
发文量
337
审稿时长
2-4 weeks
期刊介绍: The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is a scientific publication that focuses on the fields of vascular biology, atherosclerosis, and thrombosis. It is a peer-reviewed journal that publishes original research articles, reviews, and other scholarly content related to these areas. The journal is published by the American Heart Association (AHA) and the American Stroke Association (ASA). The journal was published bi-monthly until January 1992, after which it transitioned to a monthly publication schedule. The journal is aimed at a professional audience, including academic cardiologists, vascular biologists, physiologists, pharmacologists and hematologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信